Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 20 May 2008
Vol. 1, Issue 20, p. ec183
[DOI: 10.1126/stke.120ec183]

EDITORS' CHOICE

Autoimmunity Interfering with Inflammation

John F. Foley

Science Signaling, AAAS, Washington, DC 20005, USA

Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS), which causes demyelination of axons. Experimental autoimmune encephalomyelitis (EAE) is a mouse model of MS that is induced by immunizing mice with myelin oligodendrocyte glycoprotein (MOG). The best-known treatment for MS is the type I interferon (IFN), IFN-β; however, its mechanism of action is unclear. Prinz et al. found that the abundance of IFN-β was increased in the CNS of MOG-treated mice compared with untreated mice, as measured by enzyme-linked immunosorbent assays, suggesting that local, but not systemic, IFN-β abundance is important in this disease. Treatment of mice deficient in the type I IFN receptor (Ifnar–/– mice) with MOG resulted in worse disease and increased mortality compared with MOG-treated wild-type mice. Histological examination revealed that MOG-treated Ifnar–/– mice had more infiltrating myeloid cells, which included macrophages and microglia, in their spinal cords than did MOG-treated wild-type mice. The authors bred strains of mice that were Ifnar-deficient in specific cell types and exposed them to MOG. Whereas deletion of Ifnar in CD4+ T cells, B cells, astrocytes, or oligodendrocytes had little or no effect on disease outcome, deletion of Ifnar in myeloid cells led to exacerbated disease and increased mortality compared with that in wild-type mice. This was associated with the increased uptake of degraded myelin protein by Ifnar-deficient myeloid cells and the increased abundance of the proinflammatory cytokine tumor necrosis factor-{alpha} and the chemokine CCL2, which recruits myeloid cells. As Axtell and Steinman discuss, this study suggests that IFN-β acts on myeloid cells in the CNS to suppress inflammation and the processing of antigenic peptides, which would otherwise exacerbate disease by activating infiltrating T cells and causing further inflammation.

M. Prinz, H. Schmidt, A. Mildner, K.-P. Knobeloch, U.-K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, R. Lang, R. Martin, R. Gold, B. Becher, W. Brück, U. Kalinke, Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28, 675-686 (2008). [PubMed]

R. C. Axtell, L. Steinman, Type 1 interferons cool the inflamed brain. Immunity 28, 600-602 (2008). [PubMed]

Citation: J. F. Foley, Interfering with Inflammation. Sci. Signal. 1, ec183 (2008).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Science Signaling Podcast: 17 June 2008.
E. M. Adler and A. M. VanHook (2008)
Science Signaling 1, pc5
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882